According to a new report from Intel Market Research, the global Oligo Synthesis market was valued at $639 million in 2024 and is projected to reach $1,435 million by 2032, growing at an impressive CAGR of 12.5% during the forecast period (2025–2032). This growth is driven by accelerating advancements in genetic research, expanding applications in therapeutics, and rising demand for synthetic DNA/RNA across multiple industries.
Download FREE Sample Report:
Oligo Synthesis Market - View in Detailed Research Report
What is Oligo Synthesis?
Oligonucleotide synthesis (Oligo synthesis) refers to the chemical process of creating short sequences of nucleic acids (DNA or RNA) with defined structures. These oligos—typically under 100 bases in length—serve as essential tools in molecular biology, functioning as primers for PCR amplification, probes for diagnostics, and building blocks for synthetic biology applications. The technology enables precise control over nucleotide sequences, allowing researchers to incorporate modifications like fluorescent tags or chemical alterations for specialized applications.
Modern oligo synthesis has become indispensable for:
Genetic engineering and CRISPR-based gene editing
Drug development, particularly in antisense oligonucleotide therapies
Diagnostic assays including COVID-19 test development
Synthetic biology initiatives requiring custom DNA constructs
📥 Download FREE Sample Report:
Oligo Synthesis Market - View in Detailed Research Report
Key Market Drivers
1. Expanding Applications in Personalized Medicine
The rise of precision medicine has created unprecedented demand for custom oligonucleotides. With over 500 oligonucleotide-based drugs in clinical pipelines (including mRNA vaccines, siRNA, and antisense therapies), pharmaceutical companies are increasingly partnering with synthesis providers to accelerate drug development. The success of COVID-19 mRNA vaccines has further validated the potential of synthetic nucleic acids in therapeutics.
2. Breakthroughs in Gene Editing Technologies
The CRISPR revolution continues to fuel market growth, as researchers require highly specific guide RNAs (gRNAs) and donor DNA templates for genome engineering. The global gene editing market's expansion to $15 billion+ by 2030 directly correlates with rising oligo synthesis demand. New applications in agriculture (GMO development) and industrial biotechnology are creating additional growth avenues.
3. Automation and Process Optimization
Leading manufacturers are implementing high-throughput synthesis platforms and AI-driven sequence design tools to improve yield and reduce costs. Companies like Twist Bioscience have demonstrated how scalable silicon-based DNA synthesis can achieve price points previously considered impossible, democratizing access to synthetic biology tools.
Market Challenges
While prospects appear strong, the industry faces several hurdles:
Technical complexity: Synthesis of long oligonucleotides (>100 bases) remains challenging with high error rates
Supply chain vulnerabilities: Dependence on specialty phosphoramidite reagents creates bottlenecks
Intellectual property disputes: Ongoing patent conflicts around modified nucleotides and synthesis methods
Regulatory scrutiny: Increasing oversight of synthetic genetic materials due to biosecurity concerns
Segmentation Analysis
By Product Type:
Common Primer Synthesis (64% market share)
Modified Primer Synthesis (growing at faster rate due to therapeutic applications)
By End User:
Biotech Companies (75% share)
Academic & Research Institutions (25%)
By Application:
Therapeutics Development
Diagnostics
Research Tools
Agriculture Biotechnology
Regional Landscape
North America dominates with 53% share, led by U.S. biotech hubs
Asia-Pacific is fastest growing region (25% share), driven by China's genomics initiatives
Europe maintains strong position (15%) with cutting-edge research institutions
Competitive Landscape
The market features a mix of established players and innovative startups:
Thermo Fisher Scientific (Market Leader)
Merck KGaA
Integrated DNA Technologies (IDT)
GenScript Biotech
Twist Bioscience
Eurofins Genomics
LGC Biosearch Technologies
Recent strategic developments include:
Thermo Fisher's 2023 acquisition of oligo modification specialist
IDT's expansion of GMP manufacturing capacity
Asian players like Tsingke Biotechnology gaining market share
📘 Get Full Report Here:
Oligo Synthesis Market - View in Detailed Research Report
Future Outlook
The oligo synthesis market stands at an inflection point, with several transformative trends shaping its trajectory:
Therapeutic breakthroughs: Advancements in mRNA technology and gene editing continue to open new applications
Manufacturing innovations: Enzymatic synthesis and chip-based methods promise to disrupt traditional approaches
Emerging markets: Increasing biotech investment in India, Brazil and Southeast Asia creating new growth centers
Convergence with AI: Machine learning algorithms optimizing oligo design and synthesis parameters
📥 Download FREE Sample Report:
Oligo Synthesis Market - View in Detailed Research Report
About Intel Market Research
Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:
Real-time competitive benchmarking
Global clinical trial pipeline monitoring
Country-specific regulatory and pricing analysis
Over 500+ healthcare reports annually
Trusted by Fortune 500 companies, our insights empower decision-makers to drive innovation with confidence.
Website: https://www.intelmarketresearch.com
International: +1 (332) 2424 294
Asia-Pacific: +91 9169164321
LinkedIn: Follow Us